Wai Chun Bio-Technology Limited (0660.HK) HKSE

0.19

+0(+0.00%)

Updated at December 03 03:10PM

Currency In HKD

Valuation

Market Cap17.23M
Enterprise Value145.25M
P/E Ratio-2.11
PEG Ratio-0.02
Price/Sales Ratio0.04
Price/Book Ratio-0.93
Enterprise/Revenue0.21
Enterprise/EBITDA10.91

Fiscal Year

Fiscal YearJune 30, 2023
Most Recent QuarterDecember 31, 2023

Profitability

Profit Margin-0.02
Operating Margin0.02

Management Effectiveness

Return On Assets-0.06
Return On Equity0.42

Income Statement

Revenue773.65M
Revenue/Share4.58
Gross Profit50.41M
EBITDA14.89M
Net Income-15.43M
Diluted EPS-0.09

Balance Sheet

Total Cash5.44M
Total Cash/Share0.04
Total Debt137.55M
Total Debt/Equity-3.84
Current Ratio0.81
Book Value Per Share0.06

Price History

52-Week Change160.81
52-Week High0.35
52-Week Low0.06
Moving Average 50 Days0.19
Moving Average 200 Days0.15

Statistics

Average Volume69,703
Shares Outstanding178.48M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateMarch 30, 2023